{
  "profile_url": "https://www.moffitt.org/research-science/researchers/jose-alejandro-guevara",
  "last_updated": "2025-10-19T00:30:49.372073",
  "researcher_id": "29147",
  "degrees": [
    "MD",
    "PhD"
  ],
  "title": "",
  "primary_program": "Immunology",
  "research_program": "Immuno-Oncology Program",
  "overview": "Dr. Guevara-Pati\u00f1o\u2019s research is focused on identifying signaling cues that can be exploited for the benefit of cancer patients receiving T cell-based immunotherapy, by deeply understanding the immune fertile conditions that are necessary to generate robust anti-tumor T cell responses. Jos\u00e9 Alejandro is specifically interested in understanding the role of RPS6 as well as the effects of tumor-related hypoxia on anti-tumor T cells. In addition, he is implementing machine learning approaches for the development of immunological predictive biomarkers that will permit the stratification of cancer patients receiving immunotherapies.",
  "research_interests": [
    "Dr. Guevara-Pati\u00f1o\u2019s research is focused on identifying signaling cues that can be exploited for the benefit of cancer patients receiving T cell-based immunotherapy, by deeply understanding the immune fertile conditions that are necessary to generate robust anti-tumor T cell responses. Jos\u00e9 Alejandro is specifically interested in understanding the role of RPS6 as well as the effects of tumor-related hypoxia on anti-tumor T cells. In addition, he is implementing machine learning approaches for the development of immunological predictive biomarkers that will permit the stratification of cancer patients receiving immunotherapies.\n  *"
  ],
  "associations": [
    "Immunology",
    "Immuno-Oncology Program"
  ],
  "education": [
    {
      "type": "Graduate",
      "institution": "University College London, National Institute for Medical Research, UK, PhD"
    },
    {
      "type": "Medical School",
      "institution": "Universidad Central de Venezuela",
      "degree": "MD"
    },
    {
      "type": "Fellowship",
      "institution": "Memorial Sloan-Kettering Cancer Center",
      "specialty": "T Cell Development and tumor Immunology"
    }
  ],
  "publications": [
    {
      "title": "Wang X, Li T, Slebos RJC, Chaudhary R, Guevara-Patino JA, Bonomi M, Saba NF, Chung CH. Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab. Cancer Immunol Immun",
      "pubmed_id": "40056190",
      "pmc_id": "PMC11890688",
      "year": "2025",
      "journal": "74(4):142",
      "authors": ""
    },
    {
      "title": "Thatikonda S, Chaudhary R, Meshkovska Y, Biernacki M, Slebos RJC, Song X, Hall MS, Lilley K, Pilon-Thomas S, Guevara-Patino JA, Spiess PE, Chahoud J, Amelio AL, Wachter EA, Rodrigues D, Chung CH. PV-10 triggers immunogenic cell death in head and neck squamous cell carcinoma via endoplasmic reticulum stress and apoptosis. Mol Cancer Ther",
      "pubmed_id": "40552938",
      "pmc_id": "PMC12327362",
      "year": "2025",
      "authors": ""
    },
    {
      "title": "Nagy MZ, Plaza-Rojas LB, Boucher JC, Kostenko E, Austin AL, Tarhini AA, Chen Z, Du D, Ojwang' AME, Davis J, Obermayer A, Rejniak KA, Shaw TI, Guevara-Patino JA. Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients. J Immunother Cancer",
      "pubmed_id": "40010774",
      "year": "2025",
      "journal": "13(2)",
      "authors": ""
    },
    {
      "title": "Perez C, Plaza-Rojas L, Boucher JC, Nagy MZ, Kostenko E, Prajapati K, Burke B, Reyes MD, Austin AL, Zhang S, Le PT, Guevara-Patino JA. NKG2D receptor signaling shapes T cell thymic education. J Leukoc Biol",
      "pubmed_id": "37949818",
      "year": "2024",
      "journal": "115(2):306-321",
      "authors": ""
    },
    {
      "title": "Chaudhary R, Slebos RJC, Noel LC, Song F, Poole MI, Hoening DS, Hernandez-Prera JC, Conejo-Garcia JR, Guevara-Patino JA, Wang X, Xie M, Tan AC, Chung CH. EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma. Cancer Res Commun",
      "pubmed_id": "37377902",
      "pmc_id": "PMC10202124",
      "year": "2023",
      "journal": "3(5):896-907",
      "authors": ""
    },
    {
      "title": "Kohlhapp FJ, O'Sullivan JA, Moore TV, Zloza A, Guevara-Pati\u00f1o JA. NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells. Mol Immunol",
      "pubmed_id": "36634520",
      "pmc_id": "PMC9992161",
      "year": "2023",
      "journal": "155:1-6",
      "authors": ""
    },
    {
      "title": "Jain RK, Singh AM, Wang X, Guevara-Pati\u00f1o JA, Sonpavde G. Emerging monoclonal antibody therapies in the treatment of metastatic urothelial carcinoma. Expert Opin Emerg Drugs",
      "pubmed_id": "36882977",
      "year": "2023",
      "journal": "28(1):17-26",
      "authors": ""
    },
    {
      "title": "Jhawar SR, Wang SJ, Thandoni A, Bommareddy PK, Newman JH, Marzo AL, Kuzel TM, Gupta V, Reiser J, Daniels P, Schiff D, Mitchell D, LeBoeuf NR, Simmons C, Goyal S, Lasfar A, Guevara-Patino JA, Haffty BG, Kaufman HL, Silk AW, Zloza A. Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer. J Immunother Cancer",
      "pubmed_id": "37433716",
      "pmc_id": "PMC10347455",
      "year": "2023",
      "journal": "11(7)",
      "authors": ""
    },
    {
      "title": "Singh AM, Guevara-Patino JA, Wang X, Li R, Sonpavde G, Jain RK. Antibody-Drug Conjugates in the Treatment of Urothelial Cancer. BioDrugs",
      "pubmed_id": "37256534",
      "year": "2023",
      "journal": "37(4):505-520",
      "authors": ""
    },
    {
      "title": "O'Sullivan JA, Kohlhapp FJ, Zloza A, Plaza-Rojas L, Burke B, Dulin NO, Guevara-Pati\u00f1o JA. Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGF\u03b2. Int J Mol Sci",
      "pubmed_id": "36835342",
      "pmc_id": "PMC9966622",
      "year": "2023",
      "journal": "24(4)",
      "authors": ""
    }
  ],
  "grants": [
    {
      "description": "Title: Development and Implementation of Exhaustion Resistant CAR-T Cell Against Melanoma  \nAward Number:   \nSponsor: VOLO FOUNDATION  \nGuevara, J. (PD/PI)"
    },
    {
      "description": "Title: Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells  \nAward Number: 5R01CA250514-05  \nSponsor: National Cancer Institute (NCI)  \nGuevara, J. (PD/PI)",
      "source": "NCI",
      "period": "0514-05"
    },
    {
      "description": "Title: Exploratory Study of T Cell Skin Trafficking and the Role of NKG2D Signaling; Implications in Vitiligo and Melanoma  \nAward Number: 1R21AR081633-01A1  \nSponsor: National Institute on Aging (NIA)  \nGuevara, J. (PD/PI)",
      "period": "1633-01"
    },
    {
      "description": "Title: CD3z-Independent Signaling Module for CAR-T Cell Therapies Against Solid Cancer  \nAward Number: 23B08  \nSponsor: Florida Department of Health  \nGuevara, J. (PD/PI)"
    }
  ],
  "photo_url": "https://www.moffitt.org/globalassets/images/researchers_bio/GuevaraJoseAlejandro_29147.jpg",
  "contact": {
    "contact_url": "https://eforms.moffitt.org/ContactResearchersForm?PERID=29147"
  },
  "content_hash": "bf6f4b6deb74da196f1cf3bccd6a9eada765859f08dfefa9fbe67d1dcbef67ef",
  "researcher_name": "Jose Alejandro Guevara",
  "department": "Immunology"
}